Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Solitary Fibrous Tumors × Dacarbazine × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 6 Lymphoma 5 Melanoma 4 Sarcoma 2 Solitary Fibrous Tumors 1

Interventions

eribulin 1 Trabectedin 1 Doxorubicin 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03023124 2024-12-09

STRADA

Italian Sarcoma Group

Phase 2 Completed

Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡